China Signals Further Clinical Trial Policy Tightening

The nation’s top drug regulator vows to adopt ICH’s guidelines on drug safety and efficacy, after dropping the industry a bombshell with the tightening of oncology drug clinical trials a week ago.

CDE clinical trial tightening
China's CDE indicates more tightening of clinical trial policy • Source: Alamy

A top official at China’s new drug review agency, the Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA), has indicated that a further tightening of clinical trial policies is coming, hot on the heels of a toughening of guidelines governing cancer drug clinical trials on 3 July.

The regulations could address China’s currently "inadequate" requirements for drug safety and efficacy studies, Tao Wang, deputy director of the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Asia